Image

Financial Navigation and Peer Support to Improve Diabetes Outcomes

Financial Navigation and Peer Support to Improve Diabetes Outcomes

Recruiting
18-75 years
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial pilot study is to test the feasibility, acceptability, and preliminary efficacy of a combined intervention strategy of 1) technology-supported financial navigation to address economic burden of disease and 2) peer support both to facilitate linkages to clinical care and community resources to address social risks and improve participants' diabetes self-management. The main aims of this pilot study are:

  • To examine the feasibility and acceptability of technology-supported financial navigation and financial navigation with peer support
  • To examine trends in preliminary efficacy of technology-supported financial navigation and peer support versus financial navigation-alone on 1) A1c and blood pressure (primary outcomes), and 2) out-of-pocket costs, treatment-related financial stress, cost-related non-adherence behaviors, diabetes distress, diabetes self-care behaviors, and uptake of social care assistance (secondary outcomes).

The investigators will assess whether a combined intervention of technology-supported financial navigation and peer support will produce trends in superior diabetes and social care outcomes to financial navigation alone via a 2-arm randomized controlled trial.

Participants will

  • Complete 3 survey appointments at baseline, and 3 and 6 months. Each appointment will consist of a survey assessment, an HbA1C test, and two blood pressure readings over the phone.
  • Be randomized to either financial navigation only or financial navigation and peer support.

Eligibility

Inclusion Criteria:

Participants
  • 18-75 years of age
  • diagnosis of diabetes with prescribed anti-hyperglycemic medication
  • most recent (within the past 6 months) recorded hemoglobin A1c (HbA1c) level of ≥7.5% for individuals ≤70 years and >8.0% for individuals between 70-75 years in age
  • positive report of financial burden or cost-related non-adherence (CRN) using screening questions developed and validated from prior work 20-22
  • be willing to provide personal health information in order to effectively participate in the intervention

Peer Supporters:

  • International Classification of Diseases (ICD)-10 code for diabetes
  • In the past had A1cs' > 8.0% but whose most recent A1c in the prior 12 months is <8.0%.
  • Past experience with economic burden or unmet social risk factors
  • Adults 18-75 years

Exclusion Criteria:

Participants
  • a diagnosis of a serious psychiatric disorder (e.g., schizophrenia)
  • active alcohol or illicit drug use
  • current pregnancy or planning pregnancy
  • taking a medication that alters glucose metabolism (e.g., oral steroids)
  • report a comorbidity expected to limit life span to < 3 years
  • Participation in another diabetes study, but the investigators will ask them if they would like to be peer supporters

Peer Supporters:

  • A diagnosis of a serious psychiatric disorder (e.g., schizophrenia)
  • Active alcohol or illicit drug use
  • Current pregnancy or planning pregnancy

Study details
    Diabetes Mellitus
    Glucose Metabolism Disorders
    Metabolic Diseases
    Endocrine System Diseases

NCT06619834

University of Michigan

31 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.